doublezeroroulettewheel| The concept of non-alcoholic steatohepatitis (NASH) rose in intraday trading, with Furui shares rising 2.67%

May 27doublezeroroulettewheel, the concept of non-alcoholic steatohepatitis (NASH) rose intraday. As of 10:06, the overall index of non-alcoholic steatohepatitis (NASH) rose 0doublezeroroulettewheel.53%, quoted at 1050doublezeroroulettewheel.040 points.

From the perspective of individual stocks, this conceptdoublezeroroulettewheelAmong the constituent stocks of, Furui shares rose 2.67%, with Microchip Biotech, Huadong Pharmaceutical and Nuotai Biotech among the top gainers.

From a financial point of view, as of press time, the main net inflow of the non-alcoholic steatohepatitis (NASH) concept was-22.9633 million, of which Furui shares were popular with funds, with the main net inflow of 7.0563 million; Looking at the extended timeline, the sector's main net inflow of funds in the past 20 days was-481 million.

(The above content is Tencent's self-selected shares based on public information and intelligently generated by programs or algorithms. It is only used as a reference for users to watch the market, and is not used as investment advice or trading basis. The stock market is risky, please make decisions carefully.)